Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recurrence after anticoagulants are discontinued. Aspirin may be effective in preventing a recurrence of venous thromboembolism. METHODS: We randomly assigned 822 patients who had completed initial anticoagulant therapy after a first episode of unprovoked venous thromboembolism to receive aspirin, at a dose of 100 mg daily, or placebo for up to 4 years. The primary outcome was a recurrence of venous thromboembolism. RESULTS: During a median follow-up period of 37.2 months, venous thromboembolism recurred in 73 of 411 patients assigned to placebo and in 57 of 411 assigned to aspirin (a rate of 6.5% per year vs. 4.8% per year; hazard ratio with aspirin, 0.74; 95% confidence interval [CI], 0.52 to 1.05; P=0.09). Aspirin reduced the rate of the two prespecified secondary composite outcomes: the rate of venous thromboembolism, myocardial infarction, stroke, or cardiovascular death was reduced by 34% (a rate of 8.0% per year with placebo vs. 5.2% per year with aspirin; hazard ratio with aspirin, 0.66; 95% CI, 0.48 to 0.92; P=0.01), and the rate of venous thromboembolism, myocardial infarction, stroke, major bleeding, or death from any cause was reduced by 33% (hazard ratio, 0.67; 95% CI, 0.49 to 0.91; P=0.01). There was no significant between-group difference in the rates of major or clinically relevant nonmajor bleeding episodes (rate of 0.6% per year with placebo vs. 1.1% per year with aspirin, P=0.22) or serious adverse events. CONCLUSIONS: In this study, aspirin, as compared with placebo, did not significantly reduce the rate of recurrence of venous thromboembolism but resulted in a significant reduction in the rate of major vascular events, with improved net clinical benefit. These results substantiate earlier evidence of a therapeutic benefit of aspirin when it is given to patients after initial anticoagulant therapy for a first episode of unprovoked venous thromboembolism. (Funded by National Health and Medical Research Council [Australia] and others; Australian New Zealand Clinical Trials Registry number, ACTRN12605000004662.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE. 309,314,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
In the citing paper
“The WARFASA 309 and ASPIRE 318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 trials showed a decrease in recurrent VTE, as well as major vascular events, without an increased risk for clinically relevant bleeding. 309,315”
From American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism (2020) · cites this paper as [315]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Systematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Heit, J. A., Mohr, D. N., Silverstein, M. D., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.761 · Cited by 1,352
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M. J., Anderson, D. R., Turpie, A. G., Green, D., Ginsberg, J. S., Wells, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401201 · Cited by 1,072
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis
Kahn, S. R., Shrier, I., Julian, J. A., Ducruet, T., Arsenault, L., Miron, M.-J., Roussin, A., Desmarais, S., Joyal, F., Kassis, J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00004 · Cited by 854
Linkins, L.-A., Choi, P. T., & Douketis, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-11-200312020-00007 · Cited by 764
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Embolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01647-2019 · Cited by 1,619
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“Consequently, several studies have investigated the role of aspirin for the secondary prevention of VTE.309,314,315 The WARFASA309 and ASPIRE318 trials compared aspirin, 100 mg daily, with placebo for secondary prevention of recurrent VTE for patients with an initial unprovoked event, and the pooled results of the 2 t…”
BackgroundInfluentialAntithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Deep vein thrombosis and pulmonary embolism
Di Nisio, M., van Es, N., & Büller, H. R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30514-1 · Cited by 994
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
Weitz, J. I., Lensing, A. W. A., Prins, M. H., Bauersachs, R., Beyer-Westendorf, J., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700518 · Cited by 787
Self-citationKakkos, S. K., Gohel, M., Baekgaard, N., Bauersachs, R., Bellmunt-Montoya, S., Black, S. A., ten Cate-Hoek, A. J., Elalamy, I., Enzmann, F. K., Geroulakos, G., et al. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.09.023 · Cited by 743
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics
Mutua, V., & Gershwin, L. J. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08804-7 · Cited by 639
Martinod, K., Demers, M., Fuchs, T. A., Wong, S. L., Brill, A., Gallant, M., Hu, J., Wang, Y., & Wagner, D. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301059110 · Cited by 532
Mazzolai, L., Aboyans, V., Ageno, W., Agnelli, G., Alatri, A., Bauersachs, R., Brekelmans, M. P. A., Büller, H. R., Elias, A., Farge, D., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx003 · Cited by 402
“Aspirin Two studies investigated aspirin 100 mg vs placebo in patients with idiopathic VTE who completed initial anticoagulation treatment.(88,89) Pooled HR for VTE recurrence was 0.”
BackgroundTherapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 388
Management of venous thrombo-embolism: an update
Konstantinides, S., & Torbicki, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu243 · Cited by 383
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
Streiff, M. B., Agnelli, G., Connors, J. M., Crowther, M., Eichinger, S., Lopes, R., McBane, R. D., Moll, S., & Ansell, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1317-0 · Cited by 344
Khan, F., Rahman, A., Carrier, M., Kearon, C., Weitz, J. I., Schulman, S., Couturaud, F., Eichinger, S., Kyrle, P. A., Becattini, C., et al. (2019) · BMJ · doi:10.1136/bmj.l4363 · Cited by 328
Self-citationThe aspirin story – from willow to wonder drug
Desborough, M. J. R., & Keeling, D. M. (2017) · British Journal of Haematology · doi:10.1111/bjh.14520 · Cited by 328
Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism
Kearon, C., & Akl, E. A. (2014) · Blood · doi:10.1182/blood-2013-12-512681 · Cited by 279
Savchenko, A. S., Martinod, K., Seidman, M. A., Wong, S. L., Borissoff, J. I., Piazza, G., Libby, P., Goldhaber, S. Z., Mitchell, R. N., & Wagner, D. D. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12571 · Cited by 269
Yao, S., Guan, R., Huang, X., Li, Z., Sha, X., Yue, Y., Lim, E. G., Seo, H., Man, K. L., Zhu, X., et al. (2024) · IEEE Transactions on Intelligent Vehicles · doi:10.1109/tiv.2023.3307157 · Cited by 265
Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration
Simes, J., Becattini, C., Agnelli, G., Eikelboom, J. W., Kirby, A. C., Mister, R., Prandoni, P., & Brighton, T. A. (2014) · Circulation · doi:10.1161/circulationaha.114.008828 · Cited by 262
Self-citationCreager, M. A., Barnes, G. D., Giri, J., Mukherjee, D., Jones, W. S., Burnett, A. E., Carman, T., Casanegra, A. I., Castellucci, L. A., Clark, S. M., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001415 · Cited by 254
Couturaud, F., Sanchez, O., Pernod, G., Mismetti, P., Jego, P., Duhamel, E., Provost, K., dit Sollier, C. B., Presles, E., Castellant, P., et al. (2015) · JAMA · doi:10.1001/jama.2015.7046 · Cited by 249
Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review
Chopard, R., Albertsen, I. E., & Piazza, G. (2020) · JAMA · doi:10.1001/jama.2020.17272 · Cited by 244
Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases
Yeung, J., Li, W., & Holinstat, M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014530 · Cited by 242
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
Mezouar, S., Frère, C., Darbousset, R., Mege, D., Crescence, L., Dignat-George, F., Panicot-Dubois, L., & Dubois, C. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.01.006 · Cited by 218
The Role of Aspirin in the Prevention of Cardiovascular Disease
Ittaman, S. V., VanWormer, J. J., & Rezkalla, S. H. (2014) · Clinical Medicine & Research · doi:10.3121/cmr.2013.1197 · Cited by 202
Sterne, J. A., Bodalia, P. N., Bryden, P. A., Davies, P. A., López-López, J. A., Okoli, G. N., Thom, H. H., Caldwell, D. M., Dias, S., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21090 · Cited by 198
At the Dawn of Generative AI Era: A Tutorial-cum-Survey on New Frontiers in 6G Wireless Intelligence
Celik, A., & Eltawil, A. M. (2024) · IEEE Open Journal of the Communications Society · doi:10.1109/ojcoms.2024.3362271 · Cited by 194
Castellucci, L. A., Cameron, C., Le Gal, G., Rodger, M. A., Coyle, D., Wells, P. S., Clifford, T., Gandara, E., Wells, G., & Carrier, M. (2013) · BMJ · doi:10.1136/bmj.f5133 · Cited by 193
Hydrogen Peroxide Promotes Aging-Related Platelet Hyperactivation and Thrombosis
Dayal, S., Wilson, K. M., Motto, D. G., Miller, F. J., Chauhan, A. K., & Lentz, S. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000966 · Cited by 192
LAformer: Trajectory Prediction for Autonomous Driving with Lane-Aware Scene Constraints
Liu, M., Cheng, H., Chen, L., Broszio, H., Li, J., Zhao, R., Sester, M., & Yang, M. Y. (2024) · IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW) · doi:10.1109/cvprw63382.2024.00209 · Cited by 178
ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs
Swann, J. W., Garden, O. A., Fellman, C. L., Glanemann, B., Goggs, R. A. N., LeVine, D. N., Mackin, A. J., & Whitley, N. T. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15463 · Cited by 176
Immunothrombosis and thromboinflammation in host defense and disease
Martinod, K., & Deppermann, C. (2020) · Platelets · doi:10.1080/09537104.2020.1817360 · Cited by 165
Development and use of sulodexide in vascular diseases: implications for treatment
COCCHERI, S., & Mannello, F. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s6762 · Cited by 161
Chubak, J., Whitlock, E. P., Williams, S. B., Kamineni, A., Burda, B. U., Buist, D. S. M., & Anderson, M. L. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2117 · Cited by 160
2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
Konstantinides, S., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D. A., Galiè, N., Gibbs, J. S. R., Huisman, M., Humbert, M. J. C., Kucher, N., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.12.002 · Cited by 153
Mazzolai, L., Ageno, W., Alatri, A., Bauersachs, R. M., Becattini, C., Brodmann, M., Emmerich, J., Konstantinides, S., Meyer, G., Middeldorp, S., et al. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab088 · Cited by 153
Tran, H. A., Gibbs, H. H., Merriman, E., Curnow, J. L., Young, L., Bennett, A., Tan, C.-W., Chunilal, S. D., Ward, C., Baker, R. I., et al. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50004 · Cited by 152
Self-citationCreager, M. A., Barnes, G. D., Giri, J., Mukherjee, D., Jones, W. S., Burnett, A. E., Carman, T., Casanegra, A. I., Castellucci, L. A., Clark, S. M., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.11.005 · Cited by 144
Andreozzi, G. M., Bignamini, A. A., Davì, G., Palareti, G., Matuška, J., Holý, M., Pawlaczyk-Gabriel, K., Džupina, A., Юрьевич, С. Г., Didenko, Y. P., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016930 · Cited by 138
Olaf, M. F., & Cooney, R. R. (2017) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2017.06.003 · Cited by 138
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
Yeh, C. H., Gross, P. L., & Weitz, J. I. (2014) · Blood · doi:10.1182/blood-2014-03-563056 · Cited by 137
Pérez‐Sánchez, C., Ruiz‐Limón, P., Aguirre, M. A., Jiménez, Y., de la Rosa, I. A., Ábalos‐Aguilera, M. C., Rodríguez‐Ariza, A., Castro, C., Castro, R. O., Segui, P., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.04.007 · Cited by 134
Antithrombotic Agents: New Directions in Antithrombotic Therapy
Chan, N., & Weitz, J. I. (2019) · Circulation Research · doi:10.1161/circresaha.118.313155 · Cited by 132
Towards Generalizable Tumor Synthesis
Chen, Q., Chen, X., Song, H., Xiong, Z., Yuille, A., Wei, C., & Zhou, Z. (2024) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr52733.2024.01060 · Cited by 126
Azboy, İ., Barrack, R. L., Thomas, A. M. C., Haddad, F. S., & Parvizi, J. (2017) · The Bone & Joint Journal · doi:10.1302/0301-620x.99b11.bjj-2017-0337.r2 · Cited by 121
Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus
Seliverstov, E. I., Lobastov, K. V., Ilyukhin, Е. А., Apkhanova, T. V., Akhmetzyanov, R. V., Akhtyamov, I. F., Barinov, V., Bakhmetiev, A. S., Belov, M. V., Александрович, Б. С., et al. (2023) · Journal of Venous Disorders · doi:10.17116/flebo202317031152 · Cited by 121
Acute pulmonary embolism: a concise review of diagnosis and management
Rayner, M., Darvall, J. N., & Hammerschlag, G. (2018) · Internal Medicine Journal · doi:10.1111/imj.14145 · Cited by 119
T hrombotic issues in transgender medicine: A review
Shatzel, J. J., Connelly, K. J., & DeLoughery, T. G. (2016) · American Journal of Hematology · doi:10.1002/ajh.24593 · Cited by 112
Antiplatelet Therapy: Targeting the TxA2 Pathway
Fontana, P., Zufferey, A., Daali, Y., & Reny, J. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9529-1 · Cited by 109
Platelets in cancer and thrombosis
Riedl, J., Pabinger, I., & Ay, C. (2013) · Hämostaseologie · doi:10.5482/hamo-13-10-0054 · Cited by 108
Translational Implications of Platelets as Vascular First Responders
Becker, R. C., Sexton, T. R., & Smyth, S. S. (2018) · Circulation Research · doi:10.1161/circresaha.117.310939 · Cited by 107
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study
Cieślik, J., Mrozińska, S., Broniatowska, E., & Undas, A. (2017) · Blood · doi:10.1182/blood-2017-07-798306 · Cited by 102
Undas, A., Brummel‐Ziedins, K. E., & Mann, K. G. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12728 · Cited by 99
Self-citationDiretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
Filho, A. M. L., Azmus, A., Soeiro, A., Quadros, A., Avezum, Á., Marques, A., Franci, A., Manica, A., Volschan, A., de Paola, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s009 · Cited by 95
Uresandi, F., Monréal, M., García-Bragado, F., Domenech, P., Lecumberri, R., Escribano, P., Zamorano, J. L., Jiménez, S., Ruiz‐Artacho, P., Lozano, F., et al. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.07.008 · Cited by 94
Update on the management of venous thromboembolism
Bartholomew, J. R. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s3.04 · Cited by 91
Mekaj, A., Mekaj, Y., & Daci, F. T. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s92222 · Cited by 88
Venous Thromboembolism Following Hip and Knee Arthroplasty: The Role of Aspirin
Parvizi, J., Ceylan, H. H., Küçükdurmaz, F., Merli, G. J., Tuncay, İ., & Beverland, D. (2017) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.16.01253 · Cited by 85
The molecular basis for the prothrombotic state in sickle cell disease
Shet, A. S., Lizarralde-Iragorri, M. A., & Naik, R. P. P. (2020) · Haematologica · doi:10.3324/haematol.2019.239350 · Cited by 85
Dammacco, F., Vacca, A., Procaccio, P., Ria, R., Marech, I., & Racanelli, V. (2013) · Clinical and Experimental Medicine · doi:10.1007/s10238-013-0230-0 · Cited by 84
Assessing the risk of recurrent venous thromboembolism – a practical approach
Keo, H. H., Fahrni, J., Husmann, M. J. W., & Gretener, S. B. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s83718 · Cited by 81
Starikova, I., Jamaly, S., Sorrentino, A., Blöndal, T., Latysheva, N., Sovershaev, M. A., & Hansen, J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.07.005 · Cited by 75
Cohen, A. T., Hamilton, M., Bird, A., Mitchell, S. A., Li, S., Horblyuk, R. V., & Batson, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160064 · Cited by 74
Medjeral‐Thomas, N., Ziaj, S., Condon, M. B., Galliford, J. W., Levy, J. B., Cairns, T. D. H., & Griffith, M. E. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07190713 · Cited by 71
Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases
Heestermans, M., Poénou, G., Duchez, A., Hamzeh‐Cognasse, H., Bertoletti, L., & Cognasse, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113176 · Cited by 69
Platelets and Cancer-Associated Thrombosis
Connolly, G. C., Phipps, R. P., & Francis, C. W. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.04.009 · Cited by 69
Current knowledge on the genetics of incident venous thrombosis
Morange, P., & Trégouët, D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12233 · Cited by 68
Unified Conditional Image Generation for Visible-Infrared Person Re-Identification
Pan, H., Pei, W., Li, X., & He, Z. (2024) · IEEE Transactions on Information Forensics and Security · doi:10.1109/tifs.2024.3426335 · Cited by 66
Extended treatment of venous thromboembolism: a systematic review and network meta-analysis
Wang, K.-L., van Es, N., Cameron, C. G., Castellucci, L. A., Buller, H. R., & Carrier, M. (2018) · Heart · doi:10.1136/heartjnl-2018-313617 · Cited by 64
Aspirin and cancer: biological mechanisms and clinical outcomes
Elwood, P. C., Protty, M. B., Morgan, G., Pickering, J. E., Delon, C., & Watkins, J. (2022) · Open Biology · doi:10.1098/rsob.220124 · Cited by 61
Piazza, G. (2013) · JAMA · doi:10.1001/jama.2012.164493 · Cited by 60
Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against
Elwood, P. C., Morgan, G., Watkins, J., Protty, M. B., Mason, M. D., Adams, R., Dolwani, S., Pickering, J. E., Delon, C., & Longley, M. J. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02506-5 · Cited by 59
Is diabetes a hypercoagulable state? A critical appraisal
Pomero, F., Minno, M. N. D. D., Fenoglio, L. M., Gianni, M., Ageno, W., & Dentali, F. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0746-8 · Cited by 59
Tarantino, E., Amadio, P., Squellerio, I., Porro, B., Sandrini, L., Turnu, L., Cavalca, V., Tremoli, E., & Barbieri, S. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.001 · Cited by 59
Antithrombotic Management of Venous Thromboembolism
Renner, E., & Barnes, G. D. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.070 · Cited by 59
Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases
Lind, C., Flinterman, L. E., Enga, K. F., Severinsen, M. T., Kristensen, S. R., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Cannegieter, S. C., Overvad, K., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.004168 · Cited by 59
Heit, J. A., Lahr, B. D., Ashrani, A. A., Petterson, T. M., & Bailey, K. R. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.06.030 · Cited by 58
GeoSentinel: past, present and future
Hamer, D. H., Rizwan, A., Freedman, D. O., Kozarsky, P. E., & Libman, M. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa219 · Cited by 57
Aspirin for Dual Prevention of Venous and Arterial Thrombosis
Warkentin, T. E. (2012) · New England Journal of Medicine · doi:10.1056/nejme1211480 · Cited by 57
Association of platelet activation markers with cancer-associated venous thromboembolism
Riedl, J., Hell, L., Kaider, A., Koder, S., Marosi, C., Zielinski, C. C., Panzer, S., Pabinger, I., & Ay, C. (2015) · Platelets · doi:10.3109/09537104.2015.1041901 · Cited by 56
Ahmed, A. B., Koster, A., Lance, M. D., & Faraoni, D. (2017) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000708 · Cited by 56
Bauersachs, R. M., Beyer‐Westendorf, J., Bounameaux, H., Brighton, T., Cohen, A. T., Davidson, B. L., Holberg, G., Kakkar, A. K., Lensing, A. W. A., Prins, M. H., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0131 · Cited by 55
Self-citationElwood, P. C., Morgan, G., Galante, J., Chia, J. W.-K., Dolwani, S., Graziano, J. M., Kelson, M. J., Lanas, Á., Longley, M. J., Phillips, C. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166166 · Cited by 55
Venous and arterial thromboembolism in patients with inflammatory bowel diseases
Stadnicki, A., & Stadnicka, I. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i40.6757 · Cited by 55
Elevated Prothrombin Promotes Venous, but Not Arterial, Thrombosis in Mice
Aleman, M. M., Walton, B. L., Byrnes, J. R., Wang, J.-G., Heisler, M. J., Machlus, K. R., Cooley, B. C., & Wolberg, A. S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301607 · Cited by 55
Marik, P. E., & Cavallazzi, R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143252 · Cited by 53
Management of venous thromboembolism: an update
Piran, S., & Schulman, S. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0107-z · Cited by 53
Aspirin for prevention and treatment of venous thromboembolism
Becattini, C., & Agnelli, G. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.03.003 · Cited by 53
Historical Lessons in Translational Medicine: Cyclooxygenase Inhibition and P2Y12 Antagonism
Fitzgerald, D. J., & FitzGerald, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.111.300271 · Cited by 53
Hormone replacement therapy and venous thromboembolism
Eisenberger, A. B., & Westhoff, C. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.08.016 · Cited by 50
Goggs, R. A. N., Bacek, L. M., Bianco, D., Koenigshof, A. M., & Li, R. H. L. (2019) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12791 · Cited by 50
Does aspirin prevent venous thromboembolism?
Diep, R. T., & Garcia, D. A. (2020) · Hematology · doi:10.1182/hematology.2020000150 · Cited by 50
Managing pulmonary embolism from presentation to extended treatment
Cohen, A. T., Dobromirski, M., & Gurwith, M. M. P. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.09.040 · Cited by 49
How I diagnose and treat venous thromboembolism in sickle cell disease
Shet, A. S., & Wun, T. (2018) · Blood · doi:10.1182/blood-2018-03-822593 · Cited by 49
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.
Wang, K.-L., Chu, P. H., Lee, C., Pai, P. Y., Lin, P.-Y., Shyu, K. G., Chang, W., Chiu, K., Huang, C.-L., Lee, C. Y., et al. (2016) · Europe PMC (PubMed Central) · doi:10.6515/acs20151228a · Cited by 49
Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality?
Vela-Vásquez, R. N., & Romero, R. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev348 · Cited by 48
Metadata
- Authors
- Brighton, T. A., Eikelboom, J. W., Mann, K., Mister, R., Gallus, A., Ockelford, P., Gibbs, H., Hague, W., Xavier, D., Diaz, R., Kirby, A., & Simes, J.
- Affiliations
- Prince of Wales Hospital (AU)
- Population Health Research Institute (CA)
- The University of Sydney (AU)
- South Australia Pathology (AU)
- Auckland City Hospital (NZ)
- The Alfred Hospital (AU)
- St.John's Medical College Hospital (IN)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-22
- Volume
- 367
- Issue
- 21
- Pages
- 1979-1987
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2162531249
- Cited by
- 563
- References
- 24
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 37 · 2019: 30 · 2018: 35 · 2017: 49 · 2016: 51 · 2015: 56 · 2014: 60 · 2013: 69 · 2012: 8
- FWCI
- 41.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- low-dose aspirin, venous thromboembolism, recurrence prevention, unprovoked venous thromboembolism, anticoagulation discontinuation, secondary prevention, cardiovascular events, bleeding risk, major vascular events, net clinical benefit, thromboprophylaxis, stroke, myocardial infarction
- MeSH terms
- Aspirin, Double-Blind Method, Female, Follow-Up Studies, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk, Incidence, Venous Thromboembolism, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.